Oct 4 |
FDA lifts clinical hold on Avidity’s lead antibody conjugate therapy trial
|
Oct 3 |
Avidity gets FDA partial clinical hold lifted on DM1 drug candidate
|
Oct 3 |
Avidity Biosciences: Good Prospects, But We Are A Little Late
|
Oct 3 |
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
|
Oct 2 |
Avidity Biosciences: Intriguing Oligonucleotide Program To Monitor Over Longer Term
|
Sep 29 |
Is Avidity Biosciences, Inc. (RNA) the Best Performing Long Term Stock in 2024?
|
Sep 26 |
Is Avidity Biosciences Inc. (RNA) the Best Performing Small-Cap Stock in 2024?
|
Sep 5 |
Avidity Biosciences Joins Patient and Advocacy Communities in Raising Awareness During National Muscular Dystrophy Awareness Month
|
Aug 28 |
Avidity Biosciences to Participate in Upcoming Investor Conferences
|
Aug 20 |
Avidity, Kymera raise fresh funds; Walgreens partners with BARDA
|